rs5744739
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_006231.4(POLE):c.296C>T(p.Pro99Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000217 in 1,614,034 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P99A) has been classified as Uncertain significance.
Frequency
Consequence
NM_006231.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
POLE | NM_006231.4 | c.296C>T | p.Pro99Leu | missense_variant | 4/49 | ENST00000320574.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
POLE | ENST00000320574.10 | c.296C>T | p.Pro99Leu | missense_variant | 4/49 | 1 | NM_006231.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00117 AC: 178AN: 152128Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000282 AC: 71AN: 251448Hom.: 0 AF XY: 0.000213 AC XY: 29AN XY: 135908
GnomAD4 exome AF: 0.000118 AC: 172AN: 1461788Hom.: 1 Cov.: 31 AF XY: 0.000116 AC XY: 84AN XY: 727192
GnomAD4 genome AF: 0.00117 AC: 178AN: 152246Hom.: 1 Cov.: 33 AF XY: 0.00103 AC XY: 77AN XY: 74450
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Jun 18, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 15, 2021 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in individuals with cancer undergoing multi-gene panel testing (Mandelker 2017); This variant is associated with the following publications: (PMID: 15766587, 28873162) - |
Hereditary cancer-predisposing syndrome Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Mendelics | Apr 09, 2024 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | True Health Diagnostics | Oct 26, 2017 | - - |
Likely benign, criteria provided, single submitter | curation | Sema4, Sema4 | Jul 13, 2021 | - - |
POLE-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 22, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at